Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
183 Leser
Artikel bewerten:
(1)

The Business Research Company: Hospital Acquired Infections Testing Kits Market Research Shows Growth At 13% Rate With Increasing Disease Susceptibility

TBRC's global hospital acquired infections testing kits market report goes over the various drivers which will lead to the market size reaching $1.8 Bn by 2026.

LONDON, April 7, 2022 /PRNewswire/ -- The hospital acquired infections testing kits market is expected to be driven by increased incidence rates of chronic diseases. The hospital acquired infection rates are higher among patients with increased susceptibility because of old age and underlying chronic diseases, such as COVID-19.

tbrc_logo

The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The global hospital acquired infection testing kit market is expected to grow to $1.78 billion in 2026 at a CAGR of 8.8%.

Request a free sample of the Market Report

Regional Outlook Of The Hospital Acquired Infections Testing Kits Marke

North America has the largest hospital acquired infections testing kits market share, accounting for 36.2% of the total in 2021. It was followed by Asia-Pacific, and then the other regions. Going forward, the fastest-growing regions in the hospital acquired infections testing kits market will be South America, Africa and, Middle East where growth will be at CAGRs of 9.3%, 8.8% and 8.8% respectively. These will be followed by Asia Pacific, and Western Europe.

Rise in Healthcare Expenditure To Drive The Growth Of The Hospital Acquired Infections Testing Kits Marke

Increasing healthcare expenditure is predicted to upsurge the demand for the hospital acquired infections testing kits market. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the hospital acquired infections testing kits market. According to the National Health Expenditure Projections for 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Consequently, as per TBRC's hospital acquired infections testing kits industry growth analysis, the rise in healthcare spending will increase the demand for hospital acquired infections testing kits in the near future.

COVID-19 Impact On The Market

The unprecedented outbreak of coronavirus has caused a surge in demand for hospital acquired infections testing kits, due to the rise in hospital acquired infections during the pandemic. The pandemic has raised enormous quality of care concerns in hospitals, due to the rising number of patients during COVID-19 and the change in staffing numbers. Multiple hospitals have experienced an increase in staffing levels, with traveling nurses reporting that these nurses were unfamiliar with hospital's infection control processes. Such circumstances made it difficult for hospitals to maintain patient safety and quality of care. According to a U.S. Department of Health and Human Services report, one hospital in the US experienced an increase in central line infections during COVID-19, including life-threatening infections. COVID-19 patients usually experienced a lengthy stay in hospitals, making them more prone to hospital acquired infections.

See more on the Market Report

Check out similar market reports:

COVID-19 Rapid Test Kits Market 2022 - By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Kit Type (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care), And By Region, Opportunities And Strategies - Global Forecast To 2030

Hospital Supplies Global Market Report 2022 - By Type (Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) - Market Size, Trends, And Global Forecast 2022-2026

Hospitals And Outpatient Care Centers Global Market Report 2022 - By Type (Hospitals, Outpatient Care Centers), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) - Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has strategy enablement specialists in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

© 2022 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.